Efficacy and safety of paclitaxel with or without targeted therapy as second-line therapy in advanced gastric cancer: A meta-analysis

BACKGROUD: Paclitaxel (PTX) has become a widely used second-line therapy for advanced gastric cancer. There exists controversy whether targeted therapy combined with PTX can provide additional benefit over PTX alone. Therefore, a meta-analysis was carried out to evaluate the efficacy and safety of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ting, Jin, Jianjiang, Zhang, Yuefeng, Zhou, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310866/
https://www.ncbi.nlm.nih.gov/pubmed/32569214
http://dx.doi.org/10.1097/MD.0000000000020734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310866/
https://www.ncbi.nlm.nih.gov/pubmed/32569214
http://dx.doi.org/10.1097/MD.0000000000020734

Ejemplares similares